W7V Stock Overview
Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
WELL Health Technologies Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.84 |
| 52 Week High | CA$3.30 |
| 52 Week Low | CA$2.32 |
| Beta | 1.2 |
| 11 Month Change | -0.94% |
| 3 Month Change | -6.92% |
| 1 Year Change | 10.43% |
| 33 Year Change | -37.94% |
| 5 Year Change | 208.48% |
| Change since IPO | 1,898.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| W7V | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -5.4% | -1.9% | -1.8% |
| 1Y | 10.4% | 24.7% | 13.2% |
Return vs Industry: W7V underperformed the German Healthcare industry which returned 26.3% over the past year.
Return vs Market: W7V underperformed the German Market which returned 16.1% over the past year.
Price Volatility
| W7V volatility | |
|---|---|
| W7V Average Weekly Movement | 6.4% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: W7V has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: W7V's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Hamed Shahbazi | well.company |
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women’s health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners.
WELL Health Technologies Corp. Fundamentals Summary
| W7V fundamental statistics | |
|---|---|
| Market cap | €729.38m |
| Earnings (TTM) | €97.20m |
| Revenue (TTM) | €601.97m |
7.4x
P/E Ratio1.2x
P/S RatioIs W7V overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| W7V income statement (TTM) | |
|---|---|
| Revenue | CA$910.42m |
| Cost of Revenue | CA$505.54m |
| Gross Profit | CA$404.88m |
| Other Expenses | CA$257.87m |
| Earnings | CA$147.01m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 0.59 |
| Gross Margin | 44.47% |
| Net Profit Margin | 16.15% |
| Debt/Equity Ratio | 33.6% |
How did W7V perform over the long term?
See historical performance and comparison